U.S. Physical Therapy, Inc. (USPH) Stock Price, News, Quote & History
This article provides comprehensive financial information for U.S. Physical Therapy, Inc. (USPH), including its current stock price, historical performance, key financial metrics, and analyst ratings. It details the company's business operations in outpatient physical therapy and industrial injury prevention services, along with recent news and performance comparisons against the S&P 500.
U.S. Physical Therapy Hedges $170.6M Term Loan at 4.578% in SOFR Swap With Bank of America
U.S. Physical Therapy entered into a forward-starting interest rate swap with Bank of America to hedge its $170.6 million term loan. This agreement, effective June 30, 2027, fixes monthly payments at 4.578% in exchange for one-month SOFR, aiming to stabilize borrowing costs and reduce interest rate risk until April 14, 2031. The transaction is governed by an existing ISDA Master Agreement.
Physitrack plc (PTRK) Launches AI EMR, Targets U.S. PT Clinics
Physitrack plc (PTRK) has launched an AI-powered Electronic Medical Record (EMR) system for U.S. physical therapy and rehabilitation practices, offering free early access with plans for paid subscriptions by January 2027. The system integrates with Claim.MD for billing and insurance claims, targeting solo and small practices in a fragmented market. This strategic move aims to expand Physitrack's market presence and customer engagement by transitioning from an adjunct tool to a core system of record.
Us Physical Therapy Stock Price Forecast. Should You Buy USPH?
StockInvest.us has downgraded US Physical Therapy Inc (USPH) from a Strong Buy to a Hold/Accumulate rating, effective September 25, 2026. Despite the downgrade, the stock has shown a 5.37% gain since the hold signal on September 14, 2026, and is forecast to rise by 15.55% over the next three months. The analysis highlights several positive technical signals, including buy signals from both short and long-term moving averages and a recent Golden Star Signal, while also noting potential risks like falling volume on rising prices.
Technical Reactions to USPH Trends in Macro Strategies
This article provides a technical analysis of U.s. Physical Therapy Inc. (NASDAQ: USPH), highlighting neutral near-term readings and potentially stalling strong mid-term sentiment. It outlines AI-generated trading strategies including position, momentum breakout, and risk hedging, along with multi-timeframe signal analysis for support and resistance levels. The report also mentions the availability of real-time trading signals and personalized analysis for registered users.
U.S. Physical Therapy, Inc. (USPH) stock price, news, quote and history
This article provides comprehensive financial information for U.S. Physical Therapy, Inc. (USPH), including its current stock price, historical data, performance metrics against the S&P 500, and analyst insights. It details the company's operations in physical therapy and industrial injury prevention services. The report also highlights key financial figures such as market cap, P/E ratio, earnings trends, and analyst price targets.
U.S. Physical Therapy Adds Texas Children’s Technology Executive Myra Davis to Board
U.S. Physical Therapy, Inc. has appointed Myra Davis, a technology executive from Texas Children’s Hospital, to its Board of Directors. Davis brings extensive experience in healthcare technology, digital transformation, and information systems. Her appointment aims to strengthen the company's digital infrastructure as it manages a national network of 799 outpatient physical therapy clinics.
U.S. Physical Therapy Ahead on Addition to Board
U.S. Physical Therapy, Inc. (NYSE: USPH) announced the appointment of Myra Davis to its Board of Directors, effective October 1. Davis, currently Executive Vice President and Chief Information Innovation Officer at Texas Children’s Hospital, brings over two decades of CIO-level healthcare leadership experience. Following the announcement, USPH shares saw a gain of 23 cents, closing at $82.70.
Why U.S. Physical Therapy (USPH) Is Getting Attention Now
Recent leadership changes at U.S. Physical Therapy (USPH), including new CFO Nchacha Etta and board member Myra Davis, have brought renewed focus on cost control and cash flow. Despite a 30% rebound in share price over 90 days, the company's long-term returns have been weak, leading investors to re-evaluate its discounted cash flow estimates and potential undervaluation. While some analysts believe USPH is 12% undervalued based on cash flow and margin improvements, others are cautious due to Medicare reimbursement pressures and tight labor markets.
U.S. Physical Therapy appoints Myra Davis to board
U.S. Physical Therapy, Inc. has announced the appointment of Myra Davis to its Board of Directors, effective October 1, 2026. Davis brings extensive technology and leadership experience from her roles at Texas Children’s Hospital and other boards. The company, founded in 1990, operates 799 outpatient physical therapy clinics and provides a range of preventative and rehabilitative services.
U.S. Physical Therapy Announces the Appointment of New Board Member Myra Davis
U.S. Physical Therapy, Inc. has announced the appointment of Myra Davis to its Board of Directors, effective October 1, 2026. Ms. Davis, currently Executive Vice President and Chief Information Innovation Officer at Texas Children’s Hospital, brings extensive technology and leadership experience to the board. Chris Reading, Chairman and CEO, expressed confidence that her background will provide valuable perspective for the company's long-term success.
U.S. Physical Therapy Announces the Appointment of New Board Member Myra Davis
U.S. Physical Therapy, Inc. (USPH) has appointed Myra Davis to its Board of Directors, effective October 1, 2026. Davis, currently Executive Vice President and Chief Information Innovation Officer at Texas Children's Hospital, brings extensive technology, digital transformation, and leadership experience. The company believes her expertise will be valuable in positioning USPH for long-term success.
U.S. Physical Therapy appoints Myra Davis to board By Investing.com
U.S. Physical Therapy, Inc. (NYSE:USPH) has announced the appointment of Myra Davis to its Board of Directors, effective October 1, 2026. Davis, currently Executive Vice President and Chief Information Innovation Officer at Texas Children's Hospital, brings extensive technology and leadership experience to the board. U.S. Physical Therapy operates 799 outpatient clinics across 45 states, offering a range of physical therapy services and industrial injury prevention programs.
U S Physical Therapy CFO Etta Nchacha Awarded 6,831 Restricted Shares
Etta Nchacha, CFO of U S Physical Therapy Inc (NYSE:USPH), was granted 6,831 restricted common stock shares on September 14, 2026. These shares, awarded at no cost under the Company's 2003 Stock Incentive Plan, will vest in 16 installments between November 2026 and August 2030, contingent on her continuous employment. Following this transaction, Nchacha directly owns 6,831 shares.
Director Peter Minan Buys 6 Shares of US Physical Therapy Inc (U
Director Peter Minan recently purchased 6 shares of US Physical Therapy Inc (USPH), bringing his total ownership to 3,217.14 shares. This transaction continues a trend of accumulation by Minan, who has bought 786 shares and sold none over the past year, signaling confidence in the company. Despite a high price-earnings ratio, USPH is considered "Modestly Undervalued" by GuruFocus's GF Value, although broader insider activity shows a mix of buys and sells, and some gurus have trimmed their positions.
CFO’s 6,831-share grant at US Physical Therapy (USPH) will vest through 2030
US Physical Therapy (USPH) granted its EVP & CFO, Etta Nchacha, 6,831 shares of time-vested restricted stock on September 14, 2026. These shares will vest in service-based installments through August 20, 2030, contingent on her continued employment. This compensation-related grant, made under the company's 2003 Stock Incentive Plan, results in Nchacha holding 6,831 shares directly after the transaction.
U S physical therapy director Peter Minan acquires $474 in stock
Peter Minan, a director at U S Physical Therapy Inc. (USPH), recently acquired $474 worth of common stock through dividend reinvestments. These acquisitions, occurring on June 12, 2026, and September 11, 2026, increased his direct beneficial ownership to 3,217.14 shares. The company has also reported mixed Q2 2026 financial results and received a reiterated "Market Outperform" rating from Citizens.
US Physical Therapy (USPH) Taps A Global Finance Veteran As CFO
US Physical Therapy (USPH) has appointed Nchacha Etta as its new Executive Vice President and CFO, effective September 1st, 2026. Etta brings extensive financial experience from major healthcare and consumer goods companies. His appointment comes as USPH navigates a period of growth through acquisitions and partnerships, despite facing some financial pressures like declining net income and increased borrowings.
Automatic dividends add shares for US Physical Therapy (NYSE: USPH) director
US Physical Therapy (USPH) director Peter Francis Minan reported acquiring 6.14 shares of common stock through automatic dividend reinvestment. These transactions occurred on September 11, 2026, and June 12, 2026, with the latter being previously unreported. Minan also holds 1,153 restricted shares that are set to vest in tranches in November 2026 and March 2027, contingent on his continued directorship.
US Physical Therapy (USPH) Taps A Global Finance Veteran As CFO
US Physical Therapy (USPH) has appointed Nchacha Etta as its new Executive Vice President and Chief Financial Officer, effective September 1st. Etta brings extensive financial leadership experience from major healthcare and consumer goods companies. His appointment comes as USPH navigates a period of acquisitions and hospital partnerships, though the company faces challenges such as declining net income and physical therapy margin despite overall revenue growth.
U.S. Physical Therapy Presented at the 17th Annual Midwest Ideas Conference
U.S. Physical Therapy, Inc. (USPH) announced that its Chairman and CEO, Chris Reading, presented at the 17th Annual Midwest Ideas Conference on August 26, 2026. Reading discussed the healthcare operating environment, the company's initiatives, and future opportunities. USPH is a national operator of outpatient physical therapy clinics and a provider of industrial injury prevention services.
U.S. Physical Therapy Presented at the 17th Annual Midwest Ideas Conference
U.S. Physical Therapy, Inc. (USPH) Chairman and CEO Chris Reading presented at the 17th Annual Midwest Ideas Conference, discussing the healthcare operating environment, the Company's initiatives, and growth opportunities. USPH operates 798 outpatient physical therapy locations across 45 states and also provides industrial injury prevention services.
U.S. Physical Therapy (NYSE: USPH) COO surrenders stock for tax withholding
U.S. Physical Therapy (NYSE: USPH) COO Graham D. Reeve surrendered 762 shares of common stock on August 20, 2026, to satisfy tax withholding obligations related to vested equity awards. After this transaction, he directly holds 28,554 shares, which include 17,488 restricted shares with a vesting schedule extending through March 6, 2030. The shares surrendered for tax purposes were valued at $78.00 per share.
US Physical Therapy (NYSE: USPH) COO retains 39,617 shares post tax move
US Physical Therapy (NYSE: USPH) President and COO Eric Joseph Williams surrendered 714 shares of common stock at $78.00 per share to satisfy tax withholding obligations upon the vesting of equity awards. Following this transaction, he directly holds 39,617 shares, which includes 24,402 restricted shares with a vesting schedule extending through March 6, 2030, contingent on his continued employment. The transaction is categorized as neutral in filing impact and sentiment.
US Physical Therapy (USPH) lawyer surrenders stock for taxes
Richard Binstein, Executive Vice President, General Counsel, and Secretary of U.S. Physical Therapy Inc. (USPH), surrendered 450 shares of common stock on August 20, 2026, at $78.00 per share to cover tax withholding obligations upon vesting. Following this transaction, Binstein directly holds 24,417 shares, which includes 17,330 restricted shares with a vesting schedule extending through March 6, 2030, contingent on his continued employment. This insider transaction was reported via a Form 4 filing, indicating a neutral impact on the stock as it was for tax purposes rather than an open-market sale.
US Physical Therapy (NYSE: USPH) CFO covers taxes with 40 shares
US Physical Therapy's Interim CFO, Curtis Jason Travis, surrendered 40 shares of common stock on August 20, 2026, to cover tax withholding obligations stemming from equity award vesting. The shares were valued at $78.00 each. Following this transaction, Travis directly holds 3,853 shares, which includes 3,425 restricted shares that will vest in tranches through March 6, 2030, conditional on his continued employment.
New CFO Hire Might Change The Case For Investing In U.S. Physical Therapy (USPH)
U.S. Physical Therapy has appointed Nchacha Etta as its new CFO, a move that could influence the company's investment narrative. Etta's extensive background in healthcare and technology finance is expected to aid U.S. Physical Therapy in improving profitability and cost efficiency, especially given recent margin compression and underwhelming earnings. While Etta's hiring doesn't immediately alter demand, his experience is crucial for addressing reimbursement pressures and weak dividend cover.
New CFO Hire Might Change The Case For Investing In U.S. Physical Therapy (USPH)
U.S. Physical Therapy (USPH) has appointed Nchacha Etta as its new Executive Vice President and CFO, effective September 1, 2026. Etta's extensive background in healthcare and technology finance is expected to help the company address profitability and cost efficiency challenges, especially following a year of compressed net margins. While this appointment is significant, investors should remain aware of ongoing reimbursement pressure and weak dividend cover.
USPH | US Physical Therapy Inc Financials - Revenue Breakdown
This article provides a financial overview of US Physical Therapy Inc (USPH), focusing on its revenue breakdown, Congressional trading activity, and other financial metrics. It highlights that the company primarily generates revenue from physical therapy operations and notes the absence of detailed segment or geographic revenue data. The article also includes information on analyst ratings, executive compensation, and the company's Smart Score.
U.S. Physical Therapy (USPH) Names A New CFO On A Valuation Gap Story
U.S. Physical Therapy (USPH) has appointed Nchacha Etta as its new CFO and Executive Vice President, effective September 1, 2026. This leadership change comes as the company's stock shows recent momentum with a 26.23% 3-month return, despite an 8.24% decline over the past year. The company is currently valued by Simply Wall St as 16.5% undervalued at $93.67 per share, compared to its latest close of $78.21, driven by anticipated cost efficiencies and strategic acquisitions.
Q2 2026 US Physical Therapy Inc Earnings Call Transcript
US Physical Therapy Inc (USPH) reported a record second quarter in 2026, with visits per clinic per day increasing to 32.7 and a high net promoter score of 93.5. The company saw strong revenue growth in physical therapy and injury prevention, leading to a raised full-year 2025 adjusted EBITDA guidance. However, USPH continues to face challenges from Medicare rate cuts and a policy change by a large payer in Michigan, which negatively impacted the net rate per visit.
Outpatient & Specialty Care Stocks Q2 Teardown: U.S. Physical Therapy (NYSE:USPH) Vs The Rest
This article analyzes the Q2 earnings of U.S. Physical Therapy (NYSE:USPH) and several of its peers in the outpatient and specialty care industry. It highlights that while the sector saw strong Q2 results with revenues beating estimates, share prices have generally declined. The article details individual company performances, noting LifeStance Health Group (NASDAQ:LFST) as a top performer and DaVita (NYSE:DVA) as the weakest against analyst estimates.
Rice Hall James & Associates LLC Purchases New Position in U.S. Physical Therapy, Inc. $USPH
Rice Hall James & Associates LLC has acquired a new position in U.S. Physical Therapy, Inc. (NYSE:USPH), purchasing 18,628 shares valued at approximately $1.28 million. This comes as U.S. Physical Therapy reported an 8.5% year-over-year increase in quarterly revenue to $214.1 million, despite missing analyst EPS estimates with $0.75. The company also declared a quarterly dividend of $0.46 per share, and analysts maintain a "Moderate Buy" consensus with an average price target of $99.50.
Do USPH’s Softer Earnings and New CFO Appointment Reveal a Turning Point in Its Strategy?
U.S. Physical Therapy (USPH) recently reported softer Q2 2026 earnings with lower net income despite increased revenue, and declared a dividend. The company also announced Nchacha Etta as its new CFO, a move that analysts believe could signal a strategic shift. Investors are watching to see if the new CFO can improve financial discipline and profitability while maintaining growth initiatives amid current thin profit margins.
U.S. Physical Therapy (USPH) Stock Looks Overvalued On Sales As 3 Year Returns Stay Weak
U.S. Physical Therapy (USPH) stock appears overvalued based on its Price/Sales (P/S) ratio of 1.5x, which is above its fair P/S of 0.7x, despite a 15.8% increase in the past year. Investors who have held the stock for three years are still down 29.3%. The article suggests that future growth in patient volumes and reimbursement rates would need to be strong to justify the current valuation, otherwise, the stock might be paying too much in advance for potential future earnings.
Do USPH’s Softer Earnings and New CFO Appointment Reveal a Turning Point in Its Strategy?
U.S. Physical Therapy, Inc. reported softer second-quarter 2026 earnings with increased revenue but lower net income, coupled with the appointment of Nchacha Etta as its new CFO. This shift in financial performance and leadership raises questions about the company's future strategy, particularly in improving profitability and financial discipline. Investors are encouraged to consider these factors alongside the company's long-term potential in outpatient rehab services.
US Physical Therapy Appoints New Executive Vice President CFO
U.S. Physical Therapy, Inc. (USPH) has appointed Nchacha Etta as its new Executive Vice President and Chief Financial Officer, effective September 1, 2026. The two-year employment agreement includes an annual base salary of $625,000, substantial stock grants, and eligibility for bonuses and benefits. Analysts currently rate USPH stock as a "Buy" with a $98.00 price target, though TipRanks' AI Analyst, Spark, has a "Neutral" outlook due to valuation risks and pressured fundamentals despite technical strength.
U.S. Physical Therapy Announces New CFO
U.S. Physical Therapy, Inc. (USPH) has announced Nchacha Etta as its new Executive Vice President and Chief Financial Officer, effective September 1. Etta brings extensive experience from roles at Omnicell, Essilor of America, and Johnson & Johnson Vision. Jason Curtis had been serving as Interim CFO. The company, which operates nearly 800 physical therapy locations, saw its shares dip slightly following the announcement.
U.S. Physical Therapy Announces CFO
U.S. Physical Therapy, Inc. (USPH) announced the appointment of Nchacha Etta as its Executive Vice President and Chief Financial Officer, effective September 1, 2026. Mr. Etta brings extensive experience from previous CFO roles at Omnicell, Essilor of America, and Johnson & Johnson Vision. CEO Chris Reading expressed confidence in Etta's leadership and cultural fit, while also thanking Jason Curtis for serving as Interim CFO.
U.S. Physical Therapy (NYSE:USPH) Trading Down 4.8% - Here's Why
U.S. Physical Therapy (NYSE:USPH) shares dropped 4.8% to $78.81 after its latest earnings report revealed adjusted earnings of $0.75 per share, missing estimates, despite an 8.5% year-over-year revenue increase. The company announced a quarterly dividend of $0.46 per share, yielding 2.3%, and analysts generally maintain a "Moderate Buy" rating with an average price target of $99.50. Insider buying was noted, with a director purchasing 492 shares.
U.S. Physical Therapy Announces New CFO
U.S. Physical Therapy, Inc. (USPH) has announced Nchacha Etta as its new Executive Vice President and Chief Financial Officer, effective September 1. Etta brings extensive experience from previous CFO roles at Omnicell, Inc., Essilor of America, Inc., and Johnson & Johnson Vision. U.S. Physical Therapy operates nearly 800 outpatient physical therapy locations and provides industrial injury prevention services across 45 states.
U.S. Physical Therapy names Nchacha Etta as CFO
U.S. Physical Therapy, Inc. has appointed Nchacha Etta as its new Executive Vice President and Chief Financial Officer, effective September 1, 2026. Etta brings extensive financial leadership experience from companies like Omnicell, Essilor of America, and Johnson & Johnson Vision. Jason Curtis, who served as Interim CFO, will resume his role as Senior Vice President, Finance and Accounting.
U.S. Physical Therapy Names Nchacha Etta Chief Financial Officer
U.S. Physical Therapy, Inc. (NYSE: USPH) has appointed Nchacha Etta as its new Executive Vice President and Chief Financial Officer, effective September 1, 2026. Etta brings extensive experience as a public-company finance executive from previous roles at Omnicell, Essilor of America, Johnson & Johnson Vision, and The Coca-Cola Company. He will succeed Jason Curtis, who served as interim CFO and will remain as SVP of finance and accounting.
U.S. Physical Therapy Announces CFO
U.S. Physical Therapy, Inc. has appointed Nchacha Etta as its new Executive Vice President and Chief Financial Officer, effective September 1, 2026. Etta brings extensive experience from previous CFO roles at Omnicell, Inc. and Essilor of America, Inc., as well as senior finance positions at Johnson & Johnson Vision and The Coca-Cola Company. CEO Chris Reading highlighted Etta's proven track record and strong cultural fit for the company.
U.S. Physical Therapy Announces CFO
U.S. Physical Therapy, Inc. (USPH) has announced the appointment of Nchacha Etta as its Executive Vice President and Chief Financial Officer, effective September 1, 2026. Etta brings extensive experience from previous CFO roles at Omnicell, Essilor of America, and Johnson & Johnson Vision. CEO Chris Reading expressed confidence in Etta's leadership and cultural fit, while also thanking Interim CFO Jason Curtis for his contributions.
Bank of America Corp DE Grows Position in U.S. Physical Therapy, Inc. $USPH
Bank of America Corp DE increased its stake in U.S. Physical Therapy, Inc. by 10.9% in the first quarter, now holding 554,621 shares valued at $41.6 million. Despite a revenue increase of 8.5% year-over-year, the company missed adjusted earnings expectations. Analysts maintain a "Moderate Buy" rating with an average target price of $99.50, and the company announced a quarterly dividend of $0.46 per share.
Kayne Anderson Rudnick (USPH) discloses 846,674-share, 5.6% stake in US Physical Therapy
Kayne Anderson Rudnick Investment Management, LLC has filed an amended Schedule 13G, disclosing a beneficial ownership of 846,674 shares in US Physical Therapy Inc (USPH), which represents 5.6% of the company's common stock as of June 30, 2026. The firm holds both sole and shared voting and dispositive powers over these shares. This filing provides transparency regarding significant ownership stakes for regulatory purposes.
(USPH) and the Role of Price-Sensitive Allocations
This article provides an AI-generated analysis of U.s. Physical Therapy Inc. (NASDAQ: USPH), highlighting strong near and mid-term sentiment despite a weak long-term outlook. It identifies no resistance levels above the current price, suggesting compelling upside potential, and offers institutional trading strategies tailored to different risk profiles. The analysis includes position trading, momentum breakout, and risk hedging strategies, alongside multi-timeframe signal analysis.
Morgan Stanley (USPH) cuts U S Physical Therapy stake to 3.9% of shares
Morgan Stanley has reduced its beneficial ownership in U.S. Physical Therapy, Inc. (USPH) to 3.9% of common stock, filing an amended ownership report (SCHEDULE 13G/A). This new stake, totaling 596,683 shares, is below the 5% reporting threshold, indicating Morgan Stanley is no longer a beneficial owner of more than five percent of the company's common stock. The filing details shared voting power over 521,470 shares and shared dispositive power over 595,308 shares, with no sole power reported.
U.S. Physical Therapy, Inc. (NYSE:USPH) Given Consensus Recommendation of "Moderate Buy" by Brokerages
U.S. Physical Therapy, Inc. (NYSE:USPH) has received a consensus "Moderate Buy" rating from seven brokerages, with an average 12-month price target of $97.50 against its current price of $79.89. The company's latest quarterly results showed an 8.5% year-over-year revenue increase to $214.06 million, though EPS of $0.75 missed consensus estimates. A director recently purchased shares, and several institutional investors have increased their holdings, while the company also declared a quarterly dividend of $0.46 per share.
